BioSpace News Archive

Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells to its cell-based screening services.

Mardil Medical, Inc., today announced the successful completion of treatment for the third patient in the clinical trial of its improved VenTouch™ device.

Newest recommendations give fertility providers greater autonomy in making fertility care decisions in the midst of the global pandemic

A group of doctors and engineers from UC San Francisco, UC Berkeley and other hospitals and businesses today announced that they have developed a simple technique for repurposing sleep apnea machines so they can be used as ventilators as demand outstrips supply for the life-saving devices in hospitals overwhelmed by COVID-19 patients.

Essentium, Inc., led by the company’s COVID-19 Response Strategy Team, has been investigating how to best mobilize its resources and significant IP in materials and additive manufacturing production to aid in the fight against COVID-19.

Cascades (TSX: CAS), a leader in eco-friendly recovery, packaging and hygiene solutions, announces that it will supply recycled plastic needed to make medical visors to help in the fight against COVID-19.

Premier Medical Laboratory Services, an industry leading diagnostic laboratory, headquartered in Greenville, South Carolina, announced last week their status as the first laboratory in South Carolina validated for COVID-19 testing under CDC guidelines and the FDA’s Emergency Use Authorization.

Agiliti, Inc., a leading, nationwide provider of medical equipment management and service solutions, is partnering with U.S. hospitals and federal and state agencies on the front lines of the COVID-19 pandemic to deliver critical services where they’re needed..

The U.S. Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19

Medical Devices & Diagnostics (MD&D) companies know they are being impacted by the current pandemic and are seeking independent research to quantify how much their markets will decline or increase, how long the recovery will take, and what factors will determine that recovery.